Clinical Trial

Effect of Transfer Energy Capacitive and Resistive Therapy on Palmar Fibromatosis

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 2, 2026 (before its estimated May 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
The objective of the present study is to explore the effect of Transfer Energy Capacitive and Resistive Therapy (TECAR) therapy on pain, range of motion (ROM) and hand function in dupuytren's contracture patients (palmar fibromatosis).
Trial Details
NCT Number NCT07443371
Lead Sponsor Cairo University
Conditions Palmar Fibromatosis
Enrollment 36 participants
Start Date 2026-03-02
Primary Completion 2026-05-15 (estimated)
Study Completion 2026-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-02